Regional Analysis Of The MRD (Minimal Residual Disease) Testing Market : Opportunities And Challenges Till 2030 | 104 Pages Report

Short Description About MRD (Minimal Residual Disease) Testing Market:

The Global MRD (Minimal Residual Disease) Testing market is anticipated to rise at a considerable rate during the forecast period, between 2022 and 2031. In 2021, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Minimal residual disease (MRD) refers to the small number of cancer cells that remain in the body after treatment. The number of remaining cells may be so small that they do not cause any physical signs or symptoms and often cannot even be detected through traditional methods, such as viewing cells under a microscope and/or by tracking abnormal serum proteins in the blood. An MRD positive test result means that residual (remaining) disease was detected. A negative result means that residual disease was not detected,The most widely used tests to measure MRD are flow cytometry, polymerase chain reaction (PCR) and next-generation sequencing (NGS).

Due to the COVID-19 pandemic, the global MRD (Minimal Residual Disease) Testing market size is estimated to be worth USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of Percent during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe MRD (Minimal Residual Disease) Testing market is estimated at USD million in 2022, while the United States and China are forecast to reach USD million and USD million by 2028, respectively. The proportion of the United States is Percent in 2022, while Chinese percentage is Percent, and it is predicted that China market share will reach Percent in 2028, trailing a CAGR of Percent through the analysis period. As for the Europe MRD (Minimal Residual Disease) Testing landscape, Germany is projected to reach USD million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is Percent and Percent respectively for the next 6-year period.

Flow Cytometry accounting for Percent of the MRD (Minimal Residual Disease) Testing global market in 2021, is projected to value USD million by 2028, growing at a revised Percent CAGR from 2022 to 2028. While Specialty Clinics and Hospitals segment is altered to an Percent CAGR throughout this forecast period and will hold a share about Percent in 2028.

The global major manufacturers of MRD (Minimal Residual Disease) Testing include ICON plc, ArcherDX(Invitae), ARUP Laboratories, Asuragen, Cergentis B.V., Bio-Rad Laboratories, Mission Bio, Guardant Health and Invivoscribe, etc. In terms of revenue, the global 3 largest players have a Percent market share of MRD (Minimal Residual Disease) Testing in 2021.

This report focuses on MRD (Minimal Residual Disease) Testing volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall MRD (Minimal Residual Disease) Testing market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Get a Sample Copy of the MRD (Minimal Residual Disease) Testing Report 2023

Which are the driving factors of the MRD (Minimal Residual Disease) Testing market?

Growing demand for below applications around the world has had a direct impact on the growth of the MRD (Minimal Residual Disease) Testing

The MRD (Minimal Residual Disease) Testing segments and sub-section of the market are illuminated below:

Based on Product Types the Market is categorized into Below types that held the largest MRD (Minimal Residual Disease) Testing market share In 2022.

3.What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users. Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapters:

• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
• South America (Brazil, Argentina, Columbia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

This MRD (Minimal Residual Disease) Testing Market Research/Analysis Report Contains Answers to your following Questions

• What are the global trends in the MRD (Minimal Residual Disease) Testing market? Would the market witness an increase or decline in the demand in the coming years?
• What is the estimated demand for different types of products in MRD (Minimal Residual Disease) Testing? What are the upcoming industry applications and trends for MRD (Minimal Residual Disease) Testing market?
• What Are Projections of Global MRD (Minimal Residual Disease) Testing Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?
• Where will the strategic developments take the industry in the mid to long-term?
• What are the factors contributing to the final price of MRD (Minimal Residual Disease) Testing? What are the raw materials used for MRD (Minimal Residual Disease) Testing manufacturing?
• How big is the opportunity for the MRD (Minimal Residual Disease) Testing market? How will the increasing adoption of MRD (Minimal Residual Disease) Testing for mining impact the growth rate of the overall market?
• How much is the global MRD (Minimal Residual Disease) Testing market worth? What was the value of the market In 2020?
• Who are the major players operating in the MRD (Minimal Residual Disease) Testing market? Which companies are the front runners?
• Which are the recent industry trends that can be implemented to generate additional revenue streams?
• What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for MRD (Minimal Residual Disease) Testing Industry?

Customization of the Report

Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Inquire more and share questions if any before the purchase on this report at -

Detailed TOC of Global MRD (Minimal Residual Disease) Testing Market Insights and Forecast to 2031

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.3 Market by Application
1.3.1 Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global MRD (Minimal Residual Disease) Testing Market Perspective (2017-2028)
2.2 MRD (Minimal Residual Disease) Testing Growth Trends by Region
2.2.1 MRD (Minimal Residual Disease) Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 MRD (Minimal Residual Disease) Testing Historic Market Size by Region (2017-2022)
2.2.3 MRD (Minimal Residual Disease) Testing Forecasted Market Size by Region (2023-2028)
2.3 MRD (Minimal Residual Disease) Testing Market Dynamics
2.3.1 MRD (Minimal Residual Disease) Testing Industry Trends
2.3.2 MRD (Minimal Residual Disease) Testing Market Drivers
2.3.3 MRD (Minimal Residual Disease) Testing Market Challenges
2.3.4 MRD (Minimal Residual Disease) Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top MRD (Minimal Residual Disease) Testing Players by Revenue
3.1.1 Global Top MRD (Minimal Residual Disease) Testing Players by Revenue (2017-2022)
3.1.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Players (2017-2022)
3.2 Global MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by MRD (Minimal Residual Disease) Testing Revenue
3.4 Global MRD (Minimal Residual Disease) Testing Market Concentration Ratio
3.4.1 Global MRD (Minimal Residual Disease) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by MRD (Minimal Residual Disease) Testing Revenue in 2021
3.5 MRD (Minimal Residual Disease) Testing Key Players Head office and Area Served
3.6 Key Players MRD (Minimal Residual Disease) Testing Product Solution and Service
3.7 Date of Enter into MRD (Minimal Residual Disease) Testing Market
3.8 Mergers and Acquisitions, Expansion Plans

4 MRD (Minimal Residual Disease) Testing Breakdown Data by Type
4.1 Global MRD (Minimal Residual Disease) Testing Historic Market Size by Type (2017-2022)
4.2 Global MRD (Minimal Residual Disease) Testing Forecasted Market Size by Type (2023-2028)
5 MRD (Minimal Residual Disease) Testing Breakdown Data by Application
5.1 Global MRD (Minimal Residual Disease) Testing Historic Market Size by Application (2017-2022)
5.2 Global MRD (Minimal Residual Disease) Testing Forecasted Market Size by Application (2023-2028)

5 Global MRD (Minimal Residual Disease) Testing Market-Segmentation by Geography

5.1 North America
5.2 Europe
5.3 Asia-Pacific
5.4 Latin America

5.5 Middle East and Africa
6 Competitive Intelligence Company Profiles

7 Analyst's Viewpoints/Conclusions

8 Future Forecast of the Global MRD (Minimal Residual Disease) Testing Market from 2023-2031

8.1 Future Forecast of the Global MRD (Minimal Residual Disease) Testing Market from 2023-2031 Segment by Region
8.2 Global MRD (Minimal Residual Disease) Testing Production and Growth Rate Forecast by Type (2023-2031)
8.3 Global MRD (Minimal Residual Disease) Testing Consumption and Growth Rate Forecast by Application (2023-2031)

9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

Continued....

Purchase this report (Price 2900 USD for a single-user license) -

About Us:

360 Research Reports is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Research Reports, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

MENAFN16102023004576010663ID1107244335